The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Veru's Revenue for the
three
months ended in Dec. 2023 was $2.14 Mil. Veru's average Accounts Receivable for the
three
months ended in Dec. 2023 was $3.45 Mil.
Hence, Veru's Receivables Turnover for the
three
months ended in Dec. 2023 was 0.62.
Veru Receivables Turnover Historical Data
The historical data trend for Veru's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Veru's Receivables Turnover
For the Biotechnology subindustry, Veru's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veru's Receivables Turnover Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Veru's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Veru's Receivables Turnover falls into.
Veru Receivables Turnover Calculation
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
Veru's Receivables Turnover for the fiscal year that ended in Sep. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veru (NAS:VERU) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Veru Receivables Turnover Related Terms
Thank you for viewing the detailed overview of Veru's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VERU has been successfully added to your 